
 Scientific claim: An M2-like phenotype in brown adipose tissue macrophages is quickly induced by cold exposure. 
 Participant Dynamics: Practitioner vs. Decision-Maker 
 Contextual Arena: The Personal Arena (goal: to resolve a personal, high-stakes matter) 
 Interaction Trigger: An External Mandate (a new law, policy, or trend) 
 Dialogue Objective: To Define the Disagreement (map out points of conflict) 
```
Practitioner: Dr. Wallace, we need to discuss the new findings on brown adipose tissue macrophages. 

Decision-Maker: Right, Dr. Chen. I heard there's some controversy about this cold exposure claim.

Practitioner: Yes, the claim is that an M2-like phenotype is quickly induced by cold exposure in brown adipose tissue macrophages. 

Decision-Maker: And the controversy?

Practitioner: It's about the rapidity and consistency of this phenotypic shift. The external mandate from the health board now requires us to integrate these findings into our obesity treatment protocols.

Decision-Maker: But isn't the science still evolving? We don't want to prematurely adjust our protocols.

Practitioner: That's exactly my concern. The data is promising, but there are still questions about the long-term effects and reproducibility across different populations.

Decision-Maker: So, you're suggesting we delay implementation?

Practitioner: I'm suggesting we proceed with caution. More peer-reviewed studies are needed to validate these initial findings.

Decision-Maker: But the mandate is quite clear. They want action based on the current data.

Practitioner: I understand, but rushing in could lead to ineffective or even harmful outcomes. The disagreement here is about balancing innovation with prudence.

Decision-Maker: And if we don't comply, we risk losing funding. How do we navigate this?

Practitioner: Perhaps a compromise. We could start a pilot program while continuing to gather more data. This would satisfy the mandate while ensuring we're not putting patients at risk.

Decision-Maker: A pilot program might work. But we need to frame it in a way that aligns with the health board's urgency.

Practitioner: Agreed. We can highlight the potential benefits while being transparent about the need for further research. 

Decision-Maker: Alright, let's draft a proposal for this pilot. We'll need to address all stakeholder concerns. 

Practitioner: I'll get started on that. We should aim for a balanced approach here.

Decision-Maker: Let's proceed with that in mind. Thanks, Dr. Chen.
```